Compound library / Fat Loss / Metabolic
FDA-approved melanocortin-4 receptor agonist, but only for chronic weight management in specific rare genetic obesity conditions (POMC, PCSK1, or LEPR deficiency).
| Category | Fat Loss / Metabolic |
|---|---|
| Typical route | Subcutaneous |
| Half-life | ~11 days |
| Common dose range | Per FDA label, titrated; not intended for general weight loss |
| Typical cycle length | Ongoing under specialist medical supervision |
BioHack Track models Setmelanotide (Imcivree) at a half-life of 264 hours, so every dose you log is decayed against that curve and the app shows what is still circulating — not just what you typed.
Supplied pre-filled by pharmacy.
Refrigerate; do not freeze.
FDA-approved only for specific diagnosed genetic conditions confirmed by genetic testing — not a general-purpose weight-loss drug despite grey-market interest.
Track Setmelanotide (Imcivree) in BioHack Track. Half-life, dose range and route come pre-filled from this library — log a dose and the app counts your vial down, models what is in your system, and puts it on the same chart as your labs and body composition.
These open a search of each database for Setmelanotide (Imcivree) — they are not citations, and nothing here is evidence for any particular dose. The same links are in the app.
General reference compiled for use inside the app, not medical advice and not a recommendation to take anything. Dose ranges are what is commonly discussed, not a prescription. Talk to a qualified healthcare professional.